OxSonics Therapeutics

Oxford, United Kingdom · Founded 2013 · Privately Held (backing)

Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. OxSonics Therapeutics is based in Oxford, United Kingdom and was founded in 2013. Its last reported valuation was $34.6 million in Jul 2020. It has raised $30.2 million.

Last reported valuation
$34.6M
Oct 2026
Priced at
—
Total raised
$30.2M
Last round
—

Who backs OxSonics Therapeutics?

10 investors
InvestorType
Innovate UKOther
University of Oxford—
Perivoli InnovationsOther
Anjost InvestmentFamily office
Winton VenturesOther
University of Oxford EndowmentOther
Adam Parr—
Longwall Ventures—
Oxford Investment Consultants—
Oxford University Innovation—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

OxSonics Therapeutics investors

10 investors are on record for OxSonics Therapeutics, including Innovate UK, University of Oxford, Perivoli Innovations and Anjost Investment.

Free account
More of OxSonics Therapeutics with a free account
  • ·Watch OxSonics Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like OxSonics Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View